Barriers to hepatitis C virus treatment in a Canadian HIV-hepatitis C virus coinfection tertiary care clinic

被引:22
作者
McLaren, Meaghan [1 ]
Garber, Gary [1 ]
Cooper, Curtis [1 ]
机构
[1] Univ Ottawa, Ottawa Hosp, Div Infect Dis, Ottawa, ON K1H 8L6, Canada
关键词
antiviral therapy; HCV; HIV; liver;
D O I
10.1155/2008/949582
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: Despite demonstrated efficacy in HIV-hepatitis C virus (HCV) coinfection, not all patients initiate, complete or achieve success with HCV antiviral therapy. PATIENTS AND METHODS: All HIV-HCV coinfected patient consults received at The Ottawa Hospital Viral Hepatitis Clinic (Ottawa, Ontario) between June 2000 and September 2006 were identified using a clinical database. A descriptive analysis of primary and contributing factors accounting for why patients did not initiate HCV therapy, as well as the therapeutic outcomes of treated patients, was conducted. RESULTS: One hundred two consults were received. Sixty-seven per cent of patients did not initiate HCV therapy. The key primary reasons included: HIV therapy was more urgently needed (22%), loss to follow-up (12%), patients were deemed unlikely to progress to advanced liver disease (18%) and patient refusal (12%). Many patients had secondary factors contributing to the decision not to treat, including substance abuse (23%) and psychiatric illness (14%). Overall, 59% of untreated patients (40 of 68) were eventually lost to follow-up. Thirty-three per cent of referred patients started HCV therapy. Twenty-seven of 42 courses (64%) were interrupted prematurely for reasons such as virological nonresponse (48%), psychiatric complications (10%) and physical side effects (7%). Of all treatment recipients, 12 of 42 full courses of therapy were completed and three remained on HCV medication. Overall, eight of the 102 coinfected patients studied (8%) achieved a sustained virological response. DISCUSSION: Not all HIV-HCV coinfected patients who are deemed to be in need of HCV treatment are initiating therapy. Only a minority of patients who do receive treatment achieve success. Implementation of HIV treatment, patient retention, attention to substance abuse and mental health care should be the focus of efforts designed to increase HCV treatment uptake and success. This can be best achieved within a multidisciplinary model of health care delivery.
引用
收藏
页码:133 / 137
页数:5
相关论文
共 25 条
[1]   A randomized controlled psycho-education intervention trial: Improving psychological readiness for successful HIV medication adherence and reducing depression before initiating HAART [J].
Balfour, L. ;
Kowal, J. ;
Silverman, A. ;
Tasca, G. A. ;
Angel, J. B. ;
Macpherson, P. A. ;
Garber, G. ;
Cooper, C. L. ;
Cameron, D. W. .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2006, 18 (07) :830-838
[2]   Evaluation of health care needs and patient satisfaction among hepatitis C patients treated at a hospital-based, viral hepatitis clinic [J].
Balfour, L ;
Cooper, C ;
Tasca, GA ;
Kane, M ;
Kowal, J ;
Garber, G .
CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2004, 95 (04) :272-277
[3]   Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients [J].
Benhamou, Y ;
Bochet, M ;
Di Martino, V ;
Charlotte, F ;
Azria, F ;
Coutellier, A ;
Vidaud, M ;
Bricaire, F ;
Opolon, P ;
Katlama, C ;
Poynard, T .
HEPATOLOGY, 1999, 30 (04) :1054-1058
[4]  
Boulos D, 2006, Can Commun Dis Rep, V32, P165
[5]  
BUTT A, 2006, 13 C RETR OPP INF DE, P365
[6]   Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons [J].
Chung, RT ;
Andersen, J ;
Volberding, P ;
Robbins, GK ;
Liu, T ;
Sherman, KE ;
Peters, MG ;
Koziel, MJ ;
Bhan, AK ;
Alston, B ;
Colquhoun, D ;
Nevin, T ;
Harb, G ;
van der Horst, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05) :451-459
[7]   Integrating treatment for hepatitis C virus infection into an HIV clinic [J].
Clanon, KA ;
Mueller, JJ ;
Harank, M .
CLINICAL INFECTIOUS DISEASES, 2005, 40 :S362-S366
[8]   Barriers preventing liver transplantation in Canadians with HIV infection - Perceptions of HIV specialists [J].
Cooper, Curtis L. ;
DeForest, Joanne ;
Gill, John ;
Lalonde, Richard .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 21 (03) :179-182
[9]   Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: Low eligibility for interferon treatment [J].
Fleming, CA ;
Craven, DE ;
Thornton, D ;
Tumilty, S ;
Nunes, D .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (01) :97-100
[10]   Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis [J].
Graham, CS ;
Baden, LR ;
Yu, E ;
Mrus, JM ;
Carnie, J ;
Heeren, T ;
Koziel, MJ .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (04) :562-569